Global investment firm Carlyle (NASDAQ: CG) today announced it has acquired a majority stake in Knack RCM (“Knack”) and EqualizeRCM (“Equalize”), two leading U.S. healthcare revenue cycle management (“RCM”) providers, to create an AI-native, global, multi-specialty RCM platform. Equity for the investment will come from investment funds affiliated with Carlyle Asia Partners VI (CAP VI) and Carlyle Asia Partners Growth II (CAPG II).

Read More

Recent Posts

From Visibility to Action: Closing the Revenue Cycle Execution Gap

Read More
Knack RCM anesthesia platform built on decades of operating intelligence and AI-native design.
Knack RCM's anesthesia platform combines decades of operating intelligence with AI-native design to support complex revenue cycle management.

Knack RCM Spotlights Anesthesia Platform Built on Decades-deep Operating Intelligence and AI-Native Design

Read More

The Revenue Cycle Execution Gap

Read More

Why More RCM Technology Isn’t the Answer—Better Execution Is

Read More

Download Our Guide

Want to Join Knack RCM?

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Max. file size: 512 MB.